1. Interleukin-11: A Neglected Cytokine With Anti-Atherogenic Properties?. (August 2019) Authors: Poti, F.; Feuerborn, R.; Greco, D.; Battista, S.; Scalera, E.; Papotti, B.; Zanotti, I.; Nofer, J.R. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PCSK9 modulates brain cholesterol metabolism and neuroinflammation in human cell models of astrocytes and neurons. (August 2021) Authors: Zimetti, F.; Ferri, N.; Adorni, M.P.; Papotti, B.; Marchi, C.; Vandini, E.; Ronda, N.; Giuliani, D.; Bernini, F. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates cholesterol homeostasis and neuroinflammation in cell models of astrocytes and neurons. (August 2022) Authors: Papotti, B.; Marchi, C.; Adorni, M.P.; Giuliani, D.; Vilella, A.; Zimetti, F.; Ferri, N.; Bernini, F. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Serum and cerebrospinal fluid concentrations of PCSK9 and hydroxysterols in patients with cognitive impairment. (August 2022) Authors: Papotti, B.; Bertolotti, M.; Marchi, C.; Adorni, M.P.; Chiari, A.; Bedin, R.; Lupo, M.G.; Elviri, L.; Remaggi, G.; Baldelli, E.; Lancellotti, G.; Mussi, C.; Bernini, F.; Ferri, N.; Zimetti, F. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗